Status:
COMPLETED
Maternal Speech Decreases Pain Scores and Increases Oxytocin Levels in Preterm Infants During Painful Procedures
Lead Sponsor:
University of Geneva, Switzerland
Conditions:
Preterm Birth
Pain, Procedural
Eligibility:
All Genders
29-37 years
Phase:
NA
Brief Summary
Preterm infants undergo early separation from parents and are exposed to frequent painful clinical procedures, with resultant short- and long-term effects on their neurodevelopment. We aimed to establ...
Detailed Description
Preterm birth rates are continuously increasing in almost all countries, with 15 million premature infants being born every year worldwide1. Despite rapid advances in technology, the number of preterm...
Eligibility Criteria
Inclusion
- age \>29 weeks gestational age at birth,
- weight \>1000 g
- stable medical condition (absence of mechanical ventilation, no additional oxygen)
Exclusion
- For infants
- no specific pathological conditions
- no genetic abnormalities
- For mothers
- history of substance abuse
- mental health problems
Key Trial Info
Start Date :
March 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04762004
Start Date
March 7 2018
End Date
July 1 2020
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Geneva
Geneva, Switzerland, 1205